Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight
Evaluation of Dietary Supplements (Shakes and Supplements) and Personal Energy Tracking Device to Promote and Maintain Healthy Weight
1 other identifier
interventional
120
1 country
1
Brief Summary
Excessive body weight is becoming a concern around the world, for example over half of the American adult population is overweight or obese. The purpose of this study is to determine whether dietary supplements and shakes containing a combination of nutrients/ingredients individually shown in research studies to reduce hunger, enhance metabolism, reduce the body's ability to 'store' fat, and enhance energy, promote healthy body weight and composition over 12 weeks. A further study objective is to determine whether the inclusion of a personal, easy to use, energy tracking device for the measurement of daily energy intake and expenditure also helps with the promotion of healthy body weight and body composition. In this prospective, blinded study 120 volunteers who meet the entrance criteria including a BMI 25-35 kg/m2 and sign the informed consent form to participate in a 12 week long study will be recruited. All subjects will consume a multi-vitamin, mineral and fish oil supplement. Subjects will be randomly assigned to a control or experimental group and stratified by BMI 25-30 and \>30-35 kg/m2, age, and gender with an equal number of subjects in each strata across groups. A subset of subjects will also wear a personal energy tracking device. Subjects will be instructed how to incorporate the shakes and supplements into their current diet and encouraged to incorporate fruits, vegetables, whole grains, and other healthy foods into their current meals and to exercise at least 30 minutes five days per week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2007
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 12, 2007
CompletedFirst Posted
Study publicly available on registry
July 17, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedMarch 28, 2008
March 1, 2008
5 months
July 12, 2007
March 26, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body weight changes
Several measurements over 12 weeks
Secondary Outcomes (1)
Biophotonic scanner score, blood chemistry and metabolic profiles, adverse events, subjects' supplement preference, quality of life measurements
Several measurements over 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Between the ages of 18-65 years of age.
- Body Mass Index (BMI) between 25-35
- Willing to stop taking any nutritional supplements
You may not qualify if:
- Currently taking weight loss medication or supplements
- Currently smoke
- Taking any prescription medications
- Experienced at least a 10 pound weight loss over the past 2 months.
- History of serious heart problems (i.e. heart attack, angina, bypass surgery).
- Diagnosed with diabetes (insulin or non-insulin dependent)
- Known history of gastrointestinal diseases (i.e. Crohn's disease, chronic diarrhea, Inflammatory Bowel Disease)
- Undergone surgical procedure for weight loss (i.e. gastroplasty, gastric by-pass, gastrectomy, stomach stapling, gastric banding, etc).
- History of stroke or seizure activity
- Medical conditions known to affect serum lipids
- History of uncontrolled hypertension or with a current measured blood pressure with diastolic above 90 or systolic above 140 mm Hg
- A total serum cholesterol above 240 mg/dL
- Known HIV infection
- Known history of depression and currently taking anti-depression medications
- Treated for cancer in the last 5 years
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pharmanexlead
Study Sites (1)
Pharmanex
Provo, Utah, 84601, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Doug Burke, PhD
Pharmanex
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 12, 2007
First Posted
July 17, 2007
Study Start
July 1, 2007
Primary Completion
December 1, 2007
Study Completion
December 1, 2007
Last Updated
March 28, 2008
Record last verified: 2008-03